Earnings History Data for Halozyme Therapeutics, Inc. (HALO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2022 AH 4:00 PM ET
(Aug 9)
HALO Halozyme Therapeutics, Inc. 6,830 0.50 0.47 0.63 Halozyme Therapeutics Non-GAAP EPS of $0.53, revenue of $152.37M; raises FY22 outlook
[8/9/2022 4:06 PM]
44.09 0.76 
(1.75%)
47.00 3.67 
(8.47%)
31.36 - 52.98 1,966,337 1,090,000 2,751
10-05-2022 AH 4:00 PM ET
(May 10)
HALO Halozyme Therapeutics, Inc. 5,410 0.43 0.44 0.34 Halozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.02, revenue of $117.3M misses by $10.95M
[5/10/2022 4:02 PM]
38.55 0.35 
(0.92%)
38.50 0.30 
(0.79%)
31.36 - 46.62 1,198,952 1,110,000 1,039
22-02-2022 AH 4:00 PM ET
(Feb 22)
HALO Halozyme Therapeutics, Inc. 4,650 0.39 0.35 0.50 Halozyme Therapeutics Non-GAAP EPS of $0.42 beats by $0.01, revenue of $102M beats by $2.31M
[2/22/2022 4:05 PM]
33.77 0.98 
(2.99%)
32.79 0.0 
(0.00%)
31.36 - 56.40 1,059,509 710,000 14,872
02-11-2021 AH 4:00 PM ET
(Nov 2)
HALO Halozyme Therapeutics, Inc. 5,440 0.52 0.42 0.25 Halozyme Therapeutics EPS beats by $0.07, beats on revenue
[11/2/2021 4:07 PM]
40.05 0.56 
(1.42%)
40.66 1.17 
(2.96%)
30.07 - 56.40 1,181,948 670,000 8,792
09-08-2021 AH 4:00 PM ET
(Aug 9)
HALO Halozyme Therapeutics, Inc. 5,760 0.63 0.43 0.19 Halozyme Therapeutics EPS beats by $0.22, beats on revenue
[8/9/2021 4:05 PM]
41.31 0.87 
(2.15%)
46.00 5.56 
(13.75%)
25.17 - 56.40 1,663,589 720,000 126,793
10-05-2021 AH 4:00 PM ET
(May 10)
HALO Halozyme Therapeutics, Inc. 6,830 0.34 0.31 -0.04 Halozyme Therapeutics EPS beats by $0.05, beats on revenue
[5/10/2021 4:03 PM]
42.69 -3.41 
(-7.41%)
45.32 -0.78 
(-1.69%)
22.11 - 56.40 2,123,597 850,000 106
23-02-2021 AH 4:00 PM ET
(Feb 23)
HALO Halozyme Therapeutics, Inc. 6,720 0.50 0.56 -0.24 Halozyme Therapeutics EPS misses by $0.05, beats on revenue
[2/23/2021 4:06 PM]
51.87 4.66 
(9.87%)
48.99 1.78 
(3.77%)
12.71 - 56.40 10,413,487 1,016,394 35,757
02-11-2020 AH 4:00 PM ET
(Nov 2)
HALO Halozyme Therapeutics, Inc. 3,960 0.25 0.20 -0.17 Halozyme Therapeutics EPS beats by $0.05, beats on revenue
[11/2/2020 4:05 PM]
31.69 2.50 
(11.58%)
30.50 2.10 
(7.39%)
12.71 - 32.62 5,417,568 1,842,380 10,252
10-08-2020 AH 4:00 PM ET
(Aug 10)
HALO Halozyme Therapeutics, Inc. 3,980 0.19 0.25 -0.10 Halozyme Therapeutics EPS misses by $0.04, misses on revenue
[8/10/2020 4:08 PM]
28.92 0.28 
(0.98%)
27.59 -1.05 
(-3.67%)
12.71 - 29.64 587,832 845,797 1,688